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This paper aims to provide information and explanations regarding the clinically relevant options, strengths, and limitations of cardiovascular
magnetic resonance (CMR) in relation to adults with congenital heart disease (CHD). Cardiovascular magnetic resonance can provide assess-
ments of anatomical connections, biventricular function, myocardial viability, measurements of ﬂow, angiography, and more, without ionizing
radiation. It should be regarded as a necessary facility in a centre specializing in the care of adults with CHD. Also, those using CMR to
investigate acquired heart disease should be able to recognize and evaluate previously unsuspected CHD such as septal defects, anomalously
connected pulmonary veins, or double-chambered right ventricle. To realize its full potential and to avoid pitfalls, however, CMR of CHD
requires training and experience. Appropriate pathophysiological understanding is needed to evaluate cardiovascular function after surgery
for tetralogy of Fallot, transposition of the great arteries, and after Fontan operations. For these and other complex CHD, CMR should be
undertaken by specialists committed to long-term collaboration with the clinicians and surgeons managing the patients. We provide a table of
CMR acquisition protocols in relation to CHD categories as a guide towards appropriate use of this uniquely versatile imaging modality.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
Keywords Adult congenital heart disease † Cardiovascular magnetic resonance † Imaging † Tetralogy of Fallot †
Transposition of the great arteries † Atrial septal defect † Ventricular septal defect † Aortic coarctation
Introduction
This is a consensus document, commissioned, and approved by the
Nucleus members of the European Society of Cardiology Working
Groups for cardiovascular magnetic resonance (CMR) and
grown-up congenital heart disease (GUCH). Its aim is to provide
information and explanations regarding the clinically relevant
options, strengths, and limitations of CMR in adult congenital
heart disease (ACHD). It is based on the experience of the
authors supported, where available, by references to published
research, and should be read in conjunction with previously pub-
lished ‘Clinical indications for cardiovascular magnetic resonance’.
1
Advances in paediatric cardiology and cardiac surgery have
enabled the survival into adulthood of most patients born with
congenital cardiovascular malformations. This has led to the estab-
lishment of the cardiological sub-specialty of ACHD or GUCH.
2,3
Many ACHD/GUCH patients have undergone palliative or repara-
tive surgery earlier in life.
4 The operations performed for more
complex malformations are rarely curative, in which case lifelong
follow-up is generally required to optimize the quality and span
of life. As patients survive into adulthood, they may need interven-
tion or surgery for residual haemodynamic lesions, they are at risk
of arrythmias secondary to structural heart disease, and they are
also susceptible to acquired heart disease. It is important for
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evolving operative procedures used,
5,6 the possible complications,
and the questions that need to be addressed for decision making
on management or re-intervention.
The versatility and comprehensiveness of CMR
7,8 offers numer-
ous investigative possibilities, but this also presents challenges. The
relatively high costs of CMR should be weighed against the costs of
less fully informed management.
Strengths and limitations of
cardiovascular magnetic
resonance in congenital heart
disease
† Unrestricted access to cardiovascular anatomy and function,
including the systemic and pulmonary venous connections, the
right ventricle (RV) and pulmonary arteries, and the whole
aorta, without ionizing radiation.
† Well suited for repeated, life-long follow-up investigation, if
needed.
† Versatility, including measurements of biventricular size and
function regardless of chamber geometry, measurements of
ﬂow volumes, characterization of tissues, and assessment of
myocardial function, viability, and perfusion, when required.
† Applicable in women with CHD during pregnancy, but without
gadolinium contrast agent, unless essential.
† However, electrocardiogram (ECG)-gated cine images and ﬂow
maps are typically acquired over a breath-hold and not in real
time. Because of the acquisition period and the typical dimen-
sions of the voxels, thin mobile structures may not be well seen.
† Experience is needed for appropriate velocity acquisition and
interpretation (see below).
† Cardiovascular magnetic resonance lacks the portability of echo
and is not available during open heart surgery.
† Implanted pacemakers and deﬁbrillators generally preclude
CMR (see below).
Other key imaging modalities
† Chest X-ray (postero-anterior+lateral): the periodic use of
chest X-ray provides an inexpensive and inclusive overview
for serial comparison of heart size, lung parenchyma, pulmonary
vascularity, and the thoracic skeleton, with only a small dose of
ionizing radiation.
† Echocardiography: transthoracic echocardiography, and/or
transesophageal when indicated, remains the ﬁrst-line cardiovas-
cular imaging modality in patients with CHD, although subopti-
mal acoustic access can be problematic after previous
cardiovascular surgery. Echocardiography is preferable to
CMR: for the identiﬁcation of patent foramen ovale, structural
abnormalities of valve leaﬂets, and their suspensory apparatus
and infective endocardial vegetations.
† Computed tomography (CT): offers excellent spatial resol-
ution and relatively unrestricted access in much shorter acqui-
sition times than CMR. Computed tomography is well suited
for imaging the epicardial coronary arteries and their relations
to adjacent structures or conduits.
9 Electrocardiogram-gated
cine CT allows measurements of biventricular size and function,
although at a lower temporal resolution than CMR, and subject
to adequate opaciﬁcation of each intraventricular blood
volume.
10,11 In patients with a pacemaker or implantable cardi-
overter deﬁbrillator, CT provides an alternative to CMR. The
main drawback of CT is exposure to ionizing radiation and its
associated risk of cancer.
12–15 This risk is dose-, age-, and
gender-dependent and makes repeat CT examinations or
studies in young patients unattractive. Other drawbacks com-
pared with CMR include less versatile tissue characterization,
an inferior ability to evaluate cardiovascular physiology and
reliance on radio-opaque contrast agent.
When to use cardiovascular
magnetic resonance as an adjunct
to echocardiography in clinical
practice
† When an echocardiographic study is suboptimal and unable to
provide images and measurements of sufﬁcient quality to
inform clinical management.
† When echo measurements are borderline or ambiguous: ventri-
cular volumes and ejection fractions may be critical to manage-
ment, for example in the setting of volume overload, and the
same applies to the quantiﬁcation of valvular regurgitation.
When the values provided by echo are borderline or ambigu-
ous, CMR should be used in to corroborate or amend the
echo values before making clinical decisions.
† Where CMR usually informs management more effectively
– Evaluation of systemic and pulmonary veins (anomalous con-
nection or obstruction).
– Quantiﬁcation of RV volumes and ejection fraction, for
example after repair of tetralogy of Fallot (ToF).
– Evaluation of the right ventricular outﬂow tract (RVOT),
RV–pulmonary artery (PA) conduits (site of stenosis or
aneurysm), and the branch PAs.
– Quantiﬁcation of pulmonary regurgitation (PR).
– Quantiﬁcation of shunts by measurements of ﬂow in the
ascending aorta and pulmonary trunk.
– Evaluation of the entire aorta (aneurysm, dissection,
coarctation).
– Aorto-pulmonary collaterals and arterio-venous malfor-
mations (but CT gives better spatial resolution).
– Coronary anomalies and coronary artery disease, including
possible assessment of viability and perfusion (but CT is
superior for non-invasive coronary angiography).
– Detection and quantiﬁcation of myocardial ﬁbrosis in the left
ventricle (LV) and RV by late gadolinium enhancement
(LGE).
16 However, enhancement of the RV–LV insertion
regions is a common, non-speciﬁc ﬁnding where one or
both ventricles are hypertrophied or dilated and of doubtful
clinical signiﬁcance.
CMR in adults with CHD 795– Quantiﬁcation of myocardial mass. Delineating the myocar-
dium of the LV is relatively straightforward, but that of the
RV is more challenging due to a greater proportion of trabe-
culated myocardium (Figure 1), the extent of which varies
between individuals.
– Evaluation of intra- and extra-cardiac masses.
– Tissue characterization (ﬁbrosis, fat, iron loading, etc.).
General recommendations for
cardiovascular magnetic
resonance in adult congenital
heart disease
† Location of CMR resources: A dedicated CMR service
should be regarded as an indispensable facility, complementary
to echocardiography, in a centre specializing in the care of
ACHD.
3,4,17,18
† Training in CMR of ACHD: CMR studies in ACHD should be
supervised and reported by appropriately trained specialists
19,20
committed to long-term collaboration with the cardiologists and
surgeons who manage ACHD patients. Level 2 and preferably
Level 3 training in CMR is required
21 which would ideally
include the supervised interpretation of 150 adult congenital
CMR studies, having been present at the scan for at least 50
of these. Such experience is needed for appropriate optimiz-
ation of acquisition protocols with respect to the patient, the
clinical questions asked and the CMR system used.
8
† Recognition of previously unsuspected CHD in adults:
The clinicians and technicians who use CMR for the investi-
gation of acquired heart disease should be taught to recognize
and assess previously unsuspected congenital abnormalities.
† Baseline CMR: Many ACHD patients beneﬁt from at least one
CMR study. A CMR study can provide a baseline for future
reference and may identify unexpected anomalies, previously
overlooked or misinterpreted.
† Follow-up CMR: Echocardiography is generally suitable for
routine follow-up, but CMR may be indicated if change is sus-
pected. Where serial CMR studies are required, intervals
between scans depend on the risk of the condition, the
expected rate of change, and the accuracy of measurement in
a particular centre. Intervals of 3 years or more are appropriate
in most cases, but earlier restudy may be indicated by the onset
or progression of symptoms, or the presence of a lesion liable
to rapid progression.
† Biventricular volume and function measurements: CMR
has emerged as the reference standard modality for quantitative
assessment of biventricular volumes and mass.
22–24 The repro-
ducibility of LV measurements is excellent.
25 Although measure-
ments of the RV are challenging, studies have shown good
reproducibility.
26,27 In routine clinical practice, however,
measurements of biventricular size and function by CMR are
time consuming, are not easy to achieve reproducibly, requiring
dedicated software and a meticulous and clearly deﬁned tech-
nique (Figure 1). In the interests of time and reproducibility,
tracing of the RV boundary within the relatively thin compact
myocardial layer may be preferable to attempted tracing within
the trabeculations.
28 However, semi-automated methods that
identify blood-myocardial boundaries may be a practicable, if
not directly comparable, alternative.
29 Whichever approach is
used, it is crucial that longitudinal comparisons, and comparisons
withpublished normalranges,are basedon comparable methods
of acquisition and analysis. Contour data for volumetric analysis
should ideally be stored in a database and remain available for
comparison at the time of a subsequent study.
† Data storage, access, analysis, and display: The ability to
access and review the wealth of structural and functional infor-
mation contained in a CMR data set is crucial. Relevant staff
shouldhave access,with appropriate datasecurityandconﬁdenti-
alitymeasures,toanimagestorageserverfromtheirowncompu-
ter, equipped with software for CMR review and measurement.
Analysesofbiventricularfunctionandﬂowshouldfollowspeciﬁed
methodsinaparticularcentre.Resultsshouldideallybeenteredin
a database, which, as it accumulates, provides measurement
ranges, divisible into clinical categories, against which the results
in a particular patient may be assessed. Facilities for access to
anddisplayofCMRdatasetsshouldbeavailableinroomsformul-
tidisciplinary discussions of patient management.
† Comprehensive CMR acquisition in ACHD: Except in
straightforward cases where the questions to be answered are
well deﬁned,
8 it is prudent in a baseline or pre-surgical CMR
study to perform a comprehensive examination that will allow
review of the structure and function of the myocardium,
valves, and vessels through all regions of the heart and medias-
tinum. Contiguous stacks of transaxial and/or coronal cine
images can provide this. Dynamic contrast enhanced angiogra-
phy or non-contrast 3D imaging can also be valuable, although
they do not, on their own, yield cyclic functional information.
† Magnetic ﬁeld strength: Most clinical and research experi-
ence of CMR in ACHD has been at 1.5 T, and this remains
the ﬁeld strength with relatively well tried and robust acquisition
sequences. Higher ﬁeld, 3 T systems offer better signal-to-noise,
with potential advantages in terms of rapidity of acquisition or
image quality, particularly for contrast enhanced angiography
and myocardial perfusion imaging. However, these theoretical
advantages have yet to be shown to deliver improved diagnostic
performance.
30
† Catheter investigation and intervention combined with
CMR: A promising strength of this combination is improved
accuracy of measurement of pulmonary vascular resistance
based on simultaneous measurements of pulmonary ﬂow by
CMR and pressure by catheter transducer.
31 Work is progres-
sing in the use of CMR for catheter and device guidance, with
the potential advantages of 3D localization, tissue characteriz-
ation and the avoidance or reduction of ionizing radiation.
32
However, until further advances in device compatibility and
CMR technology are achieved, X-ray guidance using adjoining
space and equipment remains a necessary adjunct. This ﬁeld
remains one for research, requiring sufﬁcient allocation of
time and money, rather than for mainstream clinical use.
33,34
Apart from this, the availability of CMR as well as echocardio-
graphy reduces the need for diagnostic catheterization and
expedites the planning of percutaneous or surgical
interventions.
P.J. Kilner et al. 796Figure 1 Right ventricular volume measurement in CHD: several regions are challenging and need consistent approaches for comparison
between studies. The images are from a patient after repair of tetralogy of Fallot with infundibular resection. (A) The short-axis stack (typically
6 mm slice thickness with 4 mm gaps) is shown relative to four-chamber cine. The most basal short-axis cine should be located just within the
basal myocardium of the RV and LV at end diastole. However, the tricuspid annular plane (dotted line) may lie oblique to this slice, and usually
moves through the ﬁrst and often the second slice during systole. Care is needed to delineate areas of the ventricular but not the atrial cavities
in the more basal slices. (B) A thin, akinetic region of the RVOT (arrowed in the sagittal RVOT view) should be regarded as part of the RV up to
the (expected) level of the pulmonary valve. (C) In a mid-basal short-axis slice, the arrows indicate an akinetic region. A relatively smooth
contour is drawn immediately inside the compact myocardium of the free wall, outside the trabeculations. (D) However, at end systole, hyper-
trophied trabeculations of the muscular part of the free wall may appear to merge (asterisk). The boundary line can still be located just inside
the compact layer after viewing in cine mode. Alternatively, the dotted line drawn within the trabecular layer would give a slightly smaller
end-systolic blood volume. (E) Trabeculations are numerous towards the apex of the RV and partial volume averaging blurs boundaries, so
delineation outside the blood and trabeculations is probably the most reproducible approach. (F) Alternatively, tracing around the visible
trabeculations at all levels may be more accurate, although not necessarily more reproducible between investigators and studies. The
methods chosen need to be consistent for longitudinal comparison.
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resonance safety considerations
† Metallic objects and implantable devices: No patient or
accompanying person with a pacemaker of implanted deﬁbrilla-
tor should approach the magnet, nor anyone with a ferromag-
netic clip or steel fragment that might lie adjacent to soft
tissue of the brain or retina. However, almost all sternal
wires, clips, stents, occlusion devices, and prosthetic valves
within the chest are safe in a 1.5 T magnet, causing only local
image artefact. Newer devices that cause less artefacts may
facilitate follow-up by CMR. Safety information relating to
speciﬁc implants or situations should, however, be consulted,
as necessary.
35,36 Vigilance and strict institutional safety pro-
cedures are needed to prevent medical staff or patients inadver-
tently approaching the magnet with ferromagnetic objects such
as a gas cylinder, wheelchair, trolley, scissors, or other equip-
ment that could cause harm to themselves or a patient in the
magnetic ﬁeld.
† Gadolinium chelates: are contrast agents widely used for
CMR angiography or myocardial viability studies. It is generally
associated with less adverse reactions than iodine-based
agents, but in patients with renal failure, especially if advanced,
gadolinium administration has been linked to cases of the
severe complication of nephrogenic systemic ﬁbrosis.
37–39 In
cases where contrast agent is indicated, renal function needs
to be tested, and the potential risks weighed against the beneﬁts
of contrast enhanced rather than non-contrast CMR imaging.
40
Other limitations and
considerations
† Claustrophobia and patient compliance: CMR studies
require the patient to lie still in the tubular bore of a magnet,
which may not be tolerated by a small percentage of patients
(5%) due to claustrophobia. Anxiolytics such as oral benzo-
diazepine can be considered in individuals with mild or moder-
ate claustrophobia. Limited ability to comply with breath-hold
instructions can be an added problem in patients with Down
syndrome or other cognitive or behavioural issues, although
this is less often a problem in the adult than the paediatric popu-
lation.
41 Neither sedation nor anaesthesia can be recommended
for CMR of ACHD, unless undertaken in an appropriately
equipped and staffed centre that maintains regular relevant
experience in accordance with local practice guidelines. The
relative safety and diagnostic efﬁcacy of anaesthesia with intuba-
tion compared with sedation remains almost impossible to
determine given the rarity but potential severity of the
hazards in the CMR environment. Alternative imaging by
repeat echocardiography or by CT may be preferable.
† Intravascular pressures and jet velocities: CMR does not,
on its own, provide measurements of pressure. Pressure differ-
ences across stenoses of heart valves or large vessels can be
estimated, by applying the modiﬁed Bernoulli equation, from
measurements of jet velocities. However, CMR jet velocity
mapping requires skill. The acquisition slice, with adequate
temporal and spatial resolution and appropriate velocity encod-
ing range (VENC), should be located to transect the core of the
jet immediately downstream of the oriﬁce. The limitations of the
technique need to be recognized. The velocities of narrow,
eccentric jets through mildly regurgitant tricuspid, or pulmonary
valves, which may be used in Doppler echocardiography for
estimations of RV or PA pressure, are unlikely to be measured
accurately by CMR. Nevertheless, CMR visualization of any RV
hypertrophy, ventricular septal ﬂattening, or dilatation of the
PAs combined with their limited systolic expansion, means
that the presence and approximate severity of pulmonary
hypertension can be inferred from cine images.
† Flow measurements: The measurement of volume ﬂow in a
large vessel (Figure 2) is potentially an unrivalled strength of
CMR.
42 For derived calculations of regurgitant fraction or shunt
ﬂow,
43 the measurements of velocity through a plane transecting
a large vessel require a high standard of accuracy which, due to
slight but cumulative background phase offset errors, may not
be achievable without correction. Correction by means of the
subsequent phase contrast imaging of a static phantom and
image subtraction is effective, but takes time.
44 This approach is
recommended to test a system for clinical use and to check any
unexpected result. Image correction based on phase offset elim-
ination across regions of signal from static tissues has been
implemented,
45 but needs to be validated in clinical practice.
† Choiceofimagingparameters:ThecomplexityofCMRacqui-
sition and image reconstruction meansthat the qualityof an inves-
tigation depends on the optimization of multiple parameters. This
applies particularly to velocity mapping, inversion recovery acqui-
sitions used for myocardial ﬁbrosis imaging after gadolinium injec-
tion,
46 stress perfusion imaging,
47 and coronary angiography. In
CHD, the physician generally needs to be present during acqui-
sition to adapt the choice of image planes and sequences to the
anatomy and pathophysiology of a speciﬁc patient.
Patient preparation
† Knowledge from the case notes of the patient’s cardiac history,
previous catheter, or surgical procedures is important for
optimal planning and interpretation of CMR studies in ACHD.
Review of echocardiographic images may help towards the
choice of CMR acquisitions most likely to answer speciﬁc
remaining questions.
† Care is needed to achieve an ECG signal suitable for consistent
cardiac gating when in the magnetic ﬁeld.
† In patients with kyphoscoliosis, care must be taken to achieve a
comfortable position and to acquire key information as rapidly
as possible.
Speciﬁc indications
Congenital mitral or aortic valve disease,
before and after surgery
Although echocardiography remains the ﬁrst line of investigation,
48
CMR can contribute to the measurement of regurgitation and the
assessment of myocardial or other pathology associated with heart
P.J. Kilner et al. 798valve disease (Table 1; see also online supplementary notes to Table 1).
In patients with bicuspid aortic valve (AoV), it allows assessment of
any ascending aortic ectasia, aneurysm, or dissection. Regurgitant
or stenotic jets are visible on cine imaging, although appearances
dependon thejet size and characteristics and on the relative location
and orientation of the imaging slice. The visibility extent of a jet does
not necessarily relate to the severity of a lesion. Planimetry of an
oriﬁce, or of the cross-section of the jet immediately downstream
of the oriﬁce, is feasible in some but not all cases, depending on
the structure of the jet and the relative thickness and location of
theimagingslice.Jetvelocitymappingcancontributetoquantiﬁcation
of stenosis, but velocities may be underestimated if the slice is not
optimally located, or if the coherent core of the jet is too narrow
or fragmented to contain several whole voxels. Quantiﬁcation of
regurgitation of the inﬂow valves is feasible using ventricular stroke
volume difference in the case of a single valve lesion, or by subtrac-
tion of the outﬂow volume, measured by mapping velocities through
a plane transecting the relevant great artery, from the corresponding
ventricular stroke volume.
43 For identiﬁcation of tethering, prolapse
or failure of coaptation of all parts of the mitral (or tricuspid) leaf-
lets, a contiguous stack of cine images aligned perpendicular to
the central part of the line of coaptation is recommended.
49,50
Ross operation
The commonest complications are stenosis or regurgitation of the
RV-to-PA homograft conduit. Stenosis may be due to shrinkage
and calciﬁcation of the homograft tube, valve, or suture lines.
Any jet formation should be visualized by cine imaging and quanti-
ﬁed by jet velocity mapping, and regurgitation measured by
through-plane velocity mapping.
51,52 The autograft valve in the
aortic position should also be assessed for possible dilatation and
regurgitation particularly in the second decade after operation.
53
Possible sub-valvular pseudo-aneurym formation at the proximal
suture line should be sought. Visualization of the re-implanted cor-
onary arteries may be included, using a 3D steady state free pre-
cession (SSFP) acquisition. If there is a question of post-surgical
LV ischaemia or regional wall motion abnormality, perfusion
imaging, and/or LGE may be considered.
Aortic coarctation
Cardiovascular magnetic resonance allows assessment of resteno-
sis or aneurysm formation in the region of coarctation repair, as
well as any associated pathology such as stenosis or regurgitation
of a bicuspid AoV, aortopathy, or LV hypertrophy.
54
Figure 2 Pulmonary regurgitation measured by through-plane velocity mapping in repaired tetralogy of Fallot. (A) Cine imaging aligned with
the RVOT showed no effective pulmonary valve, with unobstructed and expansile pulmonary arteries. (B) Mapping of velocities through a plane
transecting the MPA showed (C) systolic forward ﬂow, diastolic reversed ﬂow, and late diastolic forward ﬂow with atrial systole.
CMR in adults with CHD 799Cardiovascular magnetic resonance is also helpful with a view to
balloon dilatation and stenting or surgery,
55,56 with contrast
enhanced angiography providing 3D visualization of arch geometry,
any aneurysm formation or collateral vessels. After stent place-
ment, depending on the composition of the stent material, CT
may provide a more effective assessment and should be considered
3 months after such an intervention. Collateral ﬂow can be quan-
tiﬁed by comparing through-plane measurements of ﬂow immedi-
ately proximal to the stenosis and at the level of the diaphragm.
A decrease of  10% is expected physiologically, whereas an
increase implies collateral ﬂow rejoining the descending thoracic
aorta.
57 The aortic arch with coarctation may not lie in a single
plane, and when using cine imaging and velocity mapping, it is
necessary to identify planes best suited for the depiction and
measurement of any jet ﬂow through the coarctation. The pres-
ence of diastolic prolongation of forward ﬂow, or a diastolic tail,
is a useful sign of signiﬁcant (re-)coarctation, and can be demon-
strated by plotting a velocity–time curve of jet ﬂow beyond the
coarctation.
58 Berry aneurysms of the circle of Willis or other cer-
ebral vessels occur in up to 10% of patients with coarctation
bearing the risk of rupture.
59 As rupture of a cerebral aneurysm
is associated with high mortality, screening for cerebrovascular
aneurysms is possible by an additional magnetic resonance
imaging study which may be advisable if symptoms develop.
Marfan syndrome and other connective
tissue disorders
Cardiovascular magnetic resonance studies allow measurement of
the aortic root and of any aortic regurgitation. They allow
measurements of the entire aorta and its major branches and of
ventricular and mitral valve function. It is important to check for
aortic dissection, which may be small and focal, for example by
using a 3D contrast enhanced magnetic resonance or b-SSFP acqui-
sition. Moreover, CMR can detect abnormal aortic elastic proper-
ties in affected patients before dilation occurs.
60–62 Magnetic
Table 1 Cardiovascular magnetic resonance acquisition options in adults with congenital heart disease
See online supplementary notes for explanation of the acquisition options.
CEMRA, contrast enhanced magnetic resonance; 4ch, four-chamber (plane); VLA, vertical long-axis (plane); HLA, horizontal long-axis; LVOT, left ventricular outﬂow tract; SA,
(ventricular) short-axis (plane); MPA, main pulmonary artery; ASD, atrial septal defect; TR, tricuspid regurgitation; PR, pulmonary regurgitation; MAPCAs, major aortopulmonary
collateral arteries; PAPVC, partial anomalous pulmonary venous connection; CCTGA, congenitally corrected transposition of the great arteries.
P.J. Kilner et al. 800resonance imaging of the lumbosacral spine may be used to identify
dural ectasia.
63 Cerebral contrast enhanced magnetic resonance
can be helpful in patients with Loeys-Dietz syndrome.
Ebstein anomaly and tricuspid
regurgitation
A stack of transaxial cines, supplemented by four-chamber and
other oblique cines, is recommended for visualizing the RA–RV
anatomy in Ebstein patients. Transaxial cines may be suitable for
volume measurements of the functional part of the Ebstein RV,
which may be hard to delineate in short-axis slices. In spite of atria-
lization, higher RV volumes than normal may be found in the pres-
ence of severe tricuspid regurgitation. The severity of tricuspid
regurgitation can be assessed using through-plane velocity
mapping, the VENC typically set at 250 cm/s, to depict the cross-
section of the regurgitant stream through a plane transecting the
jet immediately on the atrial side of the defect. A tricuspid regur-
gitation jet cross-section, reﬂecting the regurgitant defect, of 6  
6 mm or more can be regarded as severe. An atrial septal
defect, due to distension and gaping of a PFO, can be present in
50% of adult Ebstein patients and should be sought with an
atrial short-axis cine stack. If present, the resting shunt can be
measured by aortic and pulmonary velocity mapping. Cines may
show diastolic compression of the LV by the dilated right heart,
which can impair LV ﬁlling and so limit the cardiac output.
Repaired tetralogy of Fallot
Cardiovascular magnetic resonance has important contributions to
make in the assessment and follow-up of adults with repaired
ToF
64 and related conditions,
65,66 including those with RV–PA
conduits. Cardiovascular magnetic resonance measurements of
RV and LV function (Figure 1), any regional wall motion abnormal-
ities, PR (Figure 2), RVOT obstruction, conduit or PA stenoses, and
possible residual shunting all contribute to decisions on manage-
ment, notably the possibility of pulmonary valve replacement for
PR. The pathophysiology of PR differs from that of aortic regurgi-
tation. Free PR, with little or no effective valve function, is common
after repair of ToF. It may be tolerated without symptoms for
decades and is typically associated with a regurgitant fraction of
35–45%,
67 which should also be recorded as an indexed regur-
gitant volume.
68 However, RV dysfunction, arrhythmia, and prema-
ture death can result, with respect to which CMR late gadolinium
imaging may contribute to risk stratiﬁcation.
16 In most centres, pul-
monary valve replacement is considered in such patients, but when
to operate remains controversial, particularly if the patient is
asymptomatic and bearing in mind that a homograft replacement
may only function effectively for 15 or 20 years, or less.
69–72
Once a conduit is in position, however, progressive stenosis or
regurgitation may be treatable by percutaneous placement of a
stented valve within the relatively rigid tube of the conduit.
73,74
Cardiovascular magnetic resonance, with contrast angiography,
has a role in the selection of patients for such procedures, but
so also has CT, which allows the visualization of calcium and the
clear delineation the coronary arteries relative to a previously
placed conduit.
Studies by Therrien et al.
75 and Oosterhof et al.
76 compared
CMR measurements of RV volumes before and after surgical pul-
monary valve replacement. Both groups found reductions of RV
volumes after surgery. However, patients with pre-operative
indexed RV end-diastolic volumes above 170 mL/m
2 (or above
160 mL/m
2 in Osterhof’s study) and end-systolic volumes over
85 mL/m
2 (or over 82 mL/m
2) failed to recover to the normal
RV volume range. Although this may be taken as a guide to RV
volumes that should not be exceeded when waiting to replace a
pulmonary valve, there are more factors to be considered. Even
in the absence of an effective pulmonary valve, the amount of
regurgitation depends on factors upstream and downstream. In
occasional cases, the regurgitant fraction can exceed 50%.
77 This
may be attributable to an unusually large and compliant RV, a
large and compliant pulmonary trunk and PA branches whose
recoil contributes to the regurgitation,
78 branch PA stenosis or
elevated peripheral resistance limiting the distal escape of ﬂow,
or combinations of these.
79 In the case of unilateral branch PA ste-
nosis, comparison of right pulmonary artery and left pulmonary
artery ﬂow volumes can be informative. Contrast enhanced 3D
angiography may be used for the visualization of PA branch steno-
sis, and appropriately aligned cines can visualize jet formation and
the reduced systolic expansion of PA branches distal to a stenosis
that is obstructive enough to require relief, either percutaneously
or at the time of surgery. Measurements of relative branch PA ﬂow
and the visualization of distal PA expansion may also contribute to
the assessment of patency after stent placement. Tricuspid regur-
gitation needs to be identiﬁed and assessed, as does any residual
ventricular septal defect (VSD) patch leak and consequent shunt-
ing. Global and regional LV function, and any aortic root dilatation
or regurgitation, also need assessment.
80 In summary, the evalu-
ation of repaired ToF requires thorough assessment of the left
and right heart, extending to the branch PAs and ascending aorta.
Double-chambered right ventricle
or sub-infundibular stenosis
Results from obstructing muscular bands or ridges between the
hypertrophied body or sinus of the RV and the non-hypertrophied
infundibulum. It is usually associated with a VSD into the higher
pressure RV sinus, close to the tricuspid valve, and may progress
during adulthood. It should be possible to identify double-
chambered right ventricle (DCRV) echocardiographically, although
limited visualization may make it hard to distinguish between a jet
through a VSD, the sub-infundibular stenosis and possible infundib-
ular or pulmonary valve stenosis. Cardiovascular magnetic reson-
ance can help to differentiate between these, although ﬂow
through the VSD can be hard to detect. The sub-infundibular
origin of a DCRV jet, directed into the non-hypertrophied and
non-obstructive infundibulum, is generally visible in routine basal
short-axis cines.
81
Major aortopulmonary collateral arteries
Contrast enhanced 3D CMR angiography is valuable for delinea-
tion of all sources of pulmonary blood supply prior to surgical
or transcatheter procedures in patients with major aortopulmon-
ary collateral arteries associated with severe pulmonary stenosis
CMR in adults with CHD 801or atresia.
82 However, CT angiography is likely to depict small
vessels more clearly.
Pulmonary hypertension
Cardiovascular magnetic resonance allows assessment of RV size
and function, the size of the main and branch pulmonary arteries,
ﬂow measurement in the aorta or main PA for calculation of
indexed cardiac output, and to identify anomalies that might con-
tribute to pulmonary hypertension such as patent ductus arterio-
sus (PDA) or VSD.
83 Contrast enhanced angiography may be
used for the identiﬁcation of thrombo-embolic disease or aorto-
pulmonary collateral vessels, although contrast CT offers superior
resolution in a shorter time, which may matter in patients with
limited breath-holding ability.
Shunts: atrial septal defect, ventricular
septal defect, or patent ductus arteriosus
Cardiovascular magnetic resonance can assess questions remain-
ing, after echocardiography, about the nature of the lesion, the
amount of shunting,
43 biventricular size and function, and to
detect associated anomalies, notably the possibility of anomalous
pulmonary venous drainage.
84–86 Flow through the AoV rep-
resents Qs when there is an intracardiac left to right shunt, but
Qp when the shunt is through a PDA, with the inverse applying
to ﬂow in the pulmonary trunk.
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Transposition of the great arteries
treated by atrial switch operation
(Mustard or Senning)
Cardiovascular magnetic resonance can assess the atrial pathways
and systemic RV function.
87 With experience, cines and velocity
maps can be aligned with respect to systemic and pulmonary
venous atrial pathways.
66 Comprehensive coverage can, however,
be achieved using a stack of contiguous transaxial or coronal
cines or a 3D SSFP sequence. Bafﬂe-leaks may not be easy to ident-
ify by CMR, the suture line being long and tortuous. The measure-
ment of pulmonary relative to aortic ﬂow (Qp:Qs) may be useful,
and any incompetence of the tricuspid valve into the systemic RV
needs to be evaluated.
Transposition of the great arteries
treated by arterial switch operation
Cardiovascular magnetic resonance allows assessment of any
RVOT or supravalvar PA stenosis, branch PA stenosis, the
neo-AoV, and biventricular function.
5 Previous myocardial infarc-
tion or ﬁbrosis can be identiﬁed by LGE imaging, and assessment
of the patency of the re-implanted coronary arteries and LV per-
fusion during pharmacological stress may be attempted by CMR.
88
Transposition of the great arteries
treated by Rastelli operation
Cardiovascular magnetic resonance allows the assessment of poss-
ible stenosis or incompetence of the RV-to-PA conduit, the left
ventricular outﬂow tract, of biventricular function, and possible
residual shunt.
Congenitally corrected transposition
of the great arteries
This malformation consists of discordant atrio-ventricular and dis-
cordant ventriculo-arterial connections. If uncomplicated, the
affected patients can occasionally remain symptom free and
undiagnozed into adulthood. Associated lesions include dextrocar-
dia, a VSD, (sub-)pulmonary stenosis and Ebstein-like malformation
of the left-sided tricuspid valve. The sub-aortic RV is prone to dys-
function and regurgitation of its tricuspid valve.
89 Which ventricle
is morphologically ‘right’ and which is ‘left’ can be determined from
CMR short-axis and four-chamber cines, which show multiple
coarse trabeculations, including the moderator band, arising from
RV but not the LV side of the septum. Each atrio-ventricular
valve and ventriculo-arterial connection should be visualized by
appropriately aligned cines. Possible shunting through a VSD
should be quantiﬁed, and the presence and severity of any (sub-)
pulmonary stenosis or tricuspid regurgitation assessed.
Fontan operations for functionally
single ventricle
Fontan operations, generally performed in children with only one
effectiveventricle,resultinafundamentaldeparturefromnormalcir-
culatory dynamics.
6 The systemic and pulmonary vascular beds are
connected in series downstream of the ventricle, so eliminating
shunting at the cost of a critically elevated systemic venous pressure
that maintains ﬂow through the lungs. Earlier procedures incorpor-
atedtherightatriumbetweenthecavalveinsandpulmonaryarteries,
whereas total cavo-pulmonary connection, connecting inferior vena
cave ﬂow to the PAs via a lateral tunnel or extracardiac conduit, has
been favoured in recent years.
5 Cardiovascular magnetic resonance
allows careful assessment of the Fontan cavo-pulmonary connec-
tions, branch pulmonary arteries, pulmonary veins (which can be
compressed by the dilated right atrium of an atrio-pulmonary con-
nection), the ventricle(s), the atrio-ventricular valve(s), the ventricu-
laroutﬂowtract,andanyresidualleaksorcollateralvessels,although
artefacts from ferromagnetic occlusion devices, as seen in some
older patients, can preclude satisfactory CMR.
90 Comprehensive
coverage using a contiguous stack of transaxial cines is rec-
ommended, this generally being suitable for the identiﬁcation of
anyintra-atrial thrombus or stenosis of thecavo-pulmonary connec-
tions. Velocity mapping can be used to assess ﬂow through a sus-
pected cavo-pulmonary narrowing where a peak jet velocity
exceeding 1 m/s is likely to represent signiﬁcant stenosis, and poss-
ible shunt ﬂow through aorto-pulmonary collaterals.
91 Should con-
trast injection for angiography be considered, the timing and
distribution of contrast arrival in the PAs and its dilution by non-
opaciﬁed (inferior) caval ﬂow need to be borne in mind. Non-
contrast 3D SSFP imaging, or injection of contrast from a leg, may
bepreferable.Evaluationofmyocardialﬁbrosis byLGEmay beinfor-
mative in patients with impaired ventricular function.
Complex congenital heart disease,
operated or not
Cardiovascular magnetic resonance allows clariﬁcation of anatomy
and function, including anomalous vessels, connections, shunts, ste-
noses, abdominal situs, and possible polysplenia. Comprehensive
P.J. Kilner et al. 802cardiac, mediastinal, and upper abdominal coverage using stacks of
contiguous transaxial and coronal cines is recommended. Dynamic
contrast enhanced angiography and 3D SSFP are also useful. Cine
images should be aligned with each inﬂow and outﬂow valve, and
with any shunt ﬂow, so that connections can be established. Car-
diovascular connections are best described according to sequential
segmental analysis.
92,93 The relative pre-branch lengths of the left-
and right-sided bronchi in coronal slices can provide a useful guide
to thoracic situs, if in doubt. To distinguish a morphologically right
from a LV, useful signs include the presence of a moderator band
and additional coarse trabeculations arising from the RV side of
the inter-ventricular septum, but not from its relatively smooth
LV side.
Coronary artery anomalies
The origin and proximal course of the coronary arteries can, in
most patients, be visualized by CMR using cardiac gated 3D SSFP
angiography, with fat suppression and without contrast agent.
94,95
Either diaphragm navigator or breath-hold acquisitions are used
to minimize respiratory blurring. Acquisitions may be repeated in
different orientations if necessary. Image quality is dependent on
meticulous acquisition technique. However, contrast enhanced
multi-detector CT angiography generally gives clearer, more
extensive depiction of the coronary arteries.
Coronary artery disease
In addition to patients subject to myocardial ischaemia secondary
to Kawasaki disease or with surgically re-implanted coronaries,
acquired atheromatous disease is becoming increasingly important
as patients with CHD become older. Computed tomography
angiography is superior to CMR for coronary luminography but,
without radiation hazard, CMR can give important information
on global and regional myocardial function, viability, and
perfusion.
96,97
Conclusions
After transthoracic echocardiography, which remains the ﬁrst-line
imaging modality in ACHD, the choice of further imaging depends
on the clinical questions that remain to be addressed. Besides
tissue characterization, the strengths of CMR include comprehen-
sive access and coverage, for example by the use of a stack of
transaxial cine images or by dynamic contrast enhanced angiogra-
phy, and the relatively accurate measurements of biventricular
function and volume ﬂow. These are particularly useful in the
assessment and follow-up of adults after repairs of ToF, aortic
coarctation, and transposition of the great arteries and those
with Fontan operations or with operated or unoperated
complex malformations. In the authors’ view, a dedicated CMR
service should be regarded as a necessary facility of a centre spe-
cializing in the care of ACHD, and adults who were born with rela-
tively complex CHD should ideally be investigated as well as
managed in such a centre. To realize its full potential and to
avoid pitfalls, however, CMR of CHD requires appropriate training
and experience.
Supplementary material
Supplementary material is available at European Heart Journal
online.
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